Anastomosis Device Market

• The Anastomosis Device Market is expected to expand at a healthy growth rate during the forecast period (2025-2032), owing to the launch of new therapies, as per DelveInsight.
• The leading Anastomosis Device Companies such as B. Braun Melsungen AG, Intuitive Surgical, BAXTER, CryoLife, Inc, Johnson & Johnson Services, Inc., Medtronic, Sinolinks Medical Innovation, Inc., microcuremed, BIOWIN PHARMACEUTICAL CO., LIMITED, Waston Medical Corporation, W. L. Gore & Associates, Inc., Hangzhou Demo Medical Technology Co., Ltd, BD, Dolphin Sutures, gpcmedical, Golden Stapler Surgical Co., Ltd., JIANGSU JOYMED TECH CO., LTD, Changzhou Haiers Medical Devices Co., Ltd, Shanghai MedEco Industry Co., Ltd, ChangZhou WeiPu Medical Devices CO., LTD, and others.

Request for Unlocking the Sample Page of the "Anastomosis Device Market"

Anastomosis Device Market by Product (Surgical Staplers, Surgical Sutures, Surgical Sealants, and Surgical Adhesives), Usability (Disposable and Reusable), Application (Cardiovascular Surgery, Gastrointestinal Surgery, and Others), End-User (Hospitals & Clinics, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a substantial CAGR forecast till 2032 owing to the increasing instances of chronic disorders and the rising product developmental activities worldwide

The Anastomosis Device Market is projected to grow at a 5.3% CAGR during the forecast period from 2025 to 2032. The Anastomosis Device Market is growing significantly due to the increasing cases of colorectum cancers, coronary artery disease (CAD) among the population, clearances from regulatory bodies, and the growing burden of surgeries are factors that are expected to escalate the overall growth of the Anastomosis Device Market during the forecast period from 2025 to 2032. 

Anastomosis Device Market Dynamics

Data from the Global Cancer Observatory 2024, stated that in the year 2022 there were about 1926425 total colorectum cancer cases worldwide. The same source further stated that Asia accounted for 966399 colorectum cancer cases, comprising almost 50% of the total cases, and Europe accounted for 538262 colorectum cancer cases. The high incidence of colorectal cancer globally drives the demand for surgical treatments, where Anastomosis Device play a critical role in resecting and reconnecting the colon. These devices enhance surgical precision, reduce complications, and improve patient outcomes, making them indispensable in colorectal cancer surgeries and expanding their Market presence.

According to British Heart Foundation, Global Heart & Circulatory Diseases Factsheet (2024), it stated that around 200 million people are currently living with CAD around the world. Anastomosis Device enhance precision and efficiency in procedures like coronary artery bypass grafting (CABG), improving patient outcomes and reducing complications, making them increasingly integral to CAD Treatment.

Increased product development activities by regulatory bodies are also slated to witness Market growth for Anastomosis Device. For example, in January 2023, Lydus Medical announced that its Vesseal microvascular anastomosis suture deployment system received 510(k) clearance from the US Food and Drug Administration (FDA). Hence, the interplay of all the above-mentioned factors are expected to drive the Market for Anastomosis Device Market during the given forecast period from 2025 to 2032.

However, complications due to anastomosis, and the increasing demand for minimally invasive or non-invasive treatment approach, among others may restrict the Market growth of Anastomosis Device.

Anastomosis Device Market Segment Analysis

Anastomosis Device Market by Product (Surgical Staplers, Surgical Sutures, Surgical Sealants, and Surgical Adhesives), Usability (Disposable and Reusable), Application (Cardiovascular Surgery, Gastrointestinal Surgery, and Others), End-User (Hospitals & Clinics, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World). In the product segment of the Anastomosis Device Market, the surgical staplers category is expected to have a significant revenue share in the year 2023. This is primarily owing to the rising focus of manufacturers toward developing technologically advanced surgical staplers for an improved and efficient connection of vessels and the other various advantages offered by the category.

The surgical staplers provide quick placement, minimal tissue reaction, low risk of infection, and strong wound closure in patients with cardiovascular and gastrointestinal diseases. The staplers are also available in different shapes and sizes, easing the process of closure during surgery. Further, the increasing product launches and regulatory approvals of the Anastomosis Device will aid in increasing its demand in the Market. For instance, in March 2021, the FDA approved Viola clamps, a less proximal anastomosis device, and a new device for clamp proximal anastomosis in coronary artery bypass grafting (CABG).

Therefore, owing to the aforementioned factors, the surgical staplers category is expected to witness considerable growth eventually contributing to the overall growth of the global anastomosis device Market during the forecast period.

North America is expected to dominate the overall Anastomosis Device Market

Among all the regions, North America is estimated to hold a significant revenue share in the Anastomosis Device Market. This can be attributed to several factors such as rising colorectum cancer cases, the presence of key Market players, combined with significant advancements in product development and regulatory approvals that are acting as key factors contributing to the growth of the Anastomosis Device Market in the North America region during the forecast period from 2025 to 2032.

According to data from the Global Cancer Observatory 2024, it stated that in the year 2022, there were 183911 total colorectum cancer cases in the region. The same source further stated that the US accounted for 160186 colorectum cancer cases which is almost 87% of the total cases, and Canada accounted for 23725 colorectum cancer cases. Anastomosis Device are essential for reconnecting bowel segments during surgical resections. Advanced devices improve surgical precision, reduce complications, and enhance recovery, making them indispensable in managing colorectal cancer cases and expanding their Market.

Additionally, in October 2024, GT Metabolic Solutions Inc., a global leader in magnetic compression anastomosis surgery, announced that the U.S. Food and Drug Administration cleared GT Metabolic's MagDI™ System for side-to-side duodeno-ileal (DI) anastomosis.

The prompt and well-established healthcare services and infrastructure further contribute to the growth of the regional Anastomosis Device Market growth. The presence of key players such as Johnson & Johnson Services, Inc., B.Braun Melsungen AG, Medtronic with their strong distribution networks ensure widespread availability and accessibility of these devices across the region increasing their revenue shares in the Market, and supportive reimbursement programs providing immense growth opportunities for the same.

Therefore, the interplay of all the factors mentioned above would provide a conducive growth environment for the North America region in the Anastomosis Device Market during the forecast period from 2025 to 2032.

Anastomosis Device Companies

The leading Anastomosis Device such as B. Braun Melsungen AG, Intuitive Surgical, BAXTER, CryoLife, Inc, Johnson & Johnson Services, Inc., Medtronic, Sinolinks Medical Innovation, Inc., microcuremed, BIOWIN PHARMACEUTICAL CO., LIMITED, Waston Medical Corporation, W. L. Gore & Associates, Inc., Hangzhou Demo Medical Technology Co., Ltd, BD, Dolphin Sutures, gpcmedical, Golden Stapler Surgical Co., Ltd., JIANGSU JOYMED TECH CO., LTD, Changzhou Haiers Medical Devices Co., Ltd, Shanghai MedEco Industry Co., Ltd, ChangZhou WeiPu Medical Devices CO., LTD, and others.

Recent Developmental Activities in the Anastomosis Device Market

• In March 2025, GT Metabolic Solutions, a company specializing in magnetic surgery, earned U.S. Food and Drug Administration (FDA) clearance for a larger, 50 mm MagDI magnet to complement the system’s current 40 mm magnet. The expansion allows surgeons to accommodate a wider range of patients in magnet-assisted surgery for duodenal-ilial anastomosis. The MagDI system is currently the only FDA-cleared, commercially available product for magnetic compression anastomosis.
• In April 2021, Ethicon announced the global launch of a new powered surgical stapler, with gripping surface technology.
• In March 2021, Johnson & Johnson launched the ECHELON Stapler, which is a powered surgical stapler designed to reduce complications in surgery through more uniform tissue compression.
• In February 2021, Vascular Graft Solutions Ltd. received a receipt of Marketing authorization from the FDA for VIOLA. This is a new device for clampless proximal anastomosis in CABG.

Key Takeaways from the Anastomosis Device Market Report Study

• Market size analysis for current Anastomosis Device Market size (2023), and Market forecast for 6 years (2025 to 2032)
• Top key product/services developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
• Key Anastomosis Device Companies dominating the Global Market
• Various opportunities available for other competitors in the Anastomosis Device Market space
• What are the top-performing segments in 2023? How these segments will perform in 2032?
• Which are the top-performing regions and countries in the current Anastomosis Device Market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for Anastomosis Device Market growth in the coming future?

Target Audience who can be benefited from this Anastomosis Device Market Report Study

• Anastomosis device providers
• Research organizations and consulting Anastomosis Device Companies 
• Anastomosis Device-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and traders dealing in Anastomosis Device 
• Various end-users who want to know more about the Anastomosis Device Market and the latest developments in the Anastomosis Device Market

Stay updated with us for Recent Articles @ Latest DelveInsight Blogs